Nadia Tornieporth

Tornieporth

Nadia G. Tornieporth, MD, DTM&H, is Professor of Clinical Research and Pharmacovigilance at the University of Applied Sciences and Arts in Hannover, Germany, and currently serves as acting Head, Clinical Development, for the Coalition of Epidemic Preparedness Innovations (CEPI).

 

Previously, Dr. Tornieporth led the Global Clinical Research and Development teams at both Sanofi Pasteur and GlaxoSmithKline Biologicals. Over the course of her career, Dr. Tornieporth contributed to the successful licensure of more than 20 vaccines. She holds clinical patents for malaria and dengue vaccines and has co-authored more than 60 peer-reviewed publications in infectious diseases and vaccine development.